Secteur Eledon Pharmaceuticals, Inc.

Actions

ELDN

US28617K1016

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 20:46:48 06/07/2026 Varia. 5j. Varia. 1 janv.
3,975 USD +0,63% Graphique intraday de Eledon Pharmaceuticals, Inc. +2,71% +163,91%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+0,63%+2,71%+11,31%+28,96%+163,91%+28,14%+201,89%-47,84% - 305 M
-2,14%+3,51%+6,53%+25,35%+13,42%+74,50%+131,10%+207,95%+6 619,01% 59,1 Md
-0,93%+4,05%+27,35%+22,98%+35,67%+73,64%+90,53%-20,09% - 55,19 Md
-3,02%+0,66%+10,97%+3,94%-0,34%-13,78%-10,29%-55,56% - 24,67 Md
+0,51%+7,26%+19,30%-31,42%-35,45%+15,88%+455,34%+300,37%+985,46% 24,19 Md
+0,64%+14,41%+15,46%+8,06%+20,23%+44,27%-3,20%-72,61% - 19,69 Md
-2,19%+6,34%+13,44%+4,34%-9,84%+39,72%-29,60%-30,46%+53,70% 17,56 Md
+3,58%+25,11%+54,22%+128,64%+207,45%+196,41%+363,46%+1 679,76%+701,38% 16,22 Md
+4,91%+25,24%+33,07%+3,97%+33,48%+44,61% - - - 14,84 Md
-1,05%+1,88%+6,88%+25,74%+26,17%+25,23%+186,08%+200,71%+579,36% 14,04 Md
-0,15%+0,42%+13,32%-0,82%-9,07%+83,12%+140,11%+445,39% - 12,18 Md
-0,49%+22,33%+8,87%-27,47%-9,82%-12,23%+171,73%+72,86% - 12,03 Md
+1,17%+8,73%+10,35%-16,69%-10,98%-31,14%+614,22%+104,06%+104,87% 11,97 Md
+2,41%+7,50%+17,16%+41,58%+30,34%+413,87%+150,54%+37,20%+1 479,11% 11,83 Md
-0,15%-1,12%+27,07%+32,86%+35,79%+158,63%+156,56%+341,78%+756,80% 11,74 Md
+0,06%+26,13%+24,61%-23,74%+22,01%+29,57%+117,72%-24,98% - 10,06 Md
-4,93%+2,74%+25,66%+27,26%+355,05%+231,25%+242,59%-32,91% - 9,89 Md
-0,00%+0,17%+39,81%+19,29%+22,99%+58,76%+209,07% - - 9,77 Md
-0,23%+39,70%+54,92%+34,01%+25,38%+38,02%+364,70%+309,98% - 8,68 Md
-1,28%-0,09%+24,48%-3,59%+24,99%+80,22%+22,65%+165,27% - 8,43 Md
Moyenne -0,12%+10,34%+22,24%+15,16%+47,07%+78,93%+188,17%+198,94%+1 409,96% 17,62 Md
Moyenne pondérée par Capi. -0,50%+8,13%+20,23%+16,11%+31,81%+72,95%+163,58%+185,10%+2 778,99%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action ELDN
  4. Secteur Eledon Pharmaceuticals, Inc.